Navigation Links
N30 Pharma Announces Financing and Addition to Board
Date:5/11/2010

BOULDER, Colo., May 11 /PRNewswire/ -- N30 Pharma (N30), a biopharmaceutical company focused on the discovery and development of a new class of proprietary therapeutics that conserve endogenous, bioactive nitric oxide, announced today that it has completed a $10 million financing and expanded its Board of Directors.

Joining the Company's Board of Directors will be Dr. Howard Furst of Deerfield Management.

"I am pleased with this successful financing. It will provide resources to move our first drug, N6022 into human testing, as well as support the development of other novel new drugs from our discovery and development platform. In addition, Dr. Furst brings a wealth of healthcare investment and medical expertise to our Board," commented Charles Scoggin MD, CEO of N30.

About N30 Pharma N30 Pharma is a clinical-stage company developing s-nitrosothiol (SNO)-based therapies for major unmet needs in respiratory, cardiovascular, and inflammatory diseases. N30 drugs target s-nitrosoglutathione reductase (GSNOR), the only druggable enzyme that consumes s-nitrosoglutathione (GSNO), a central regulator of the endogenous nitric oxide pool. GSNO, and other SNO's are important modulators of inflammation as well as airway and vascular smooth muscle. N30 is a privately held company headquartered in Boulder, Colorado.


'/>"/>
SOURCE N30 Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
3. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
4. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
5. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
9. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Baxa Announces 2008 Dates for STAR Center Professional Pharmacy and Cleanroom Training
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... In contrast to traditional LED lights ... colors, Valoya uses proprietary LED technology to incorporate their ... uniformity which is critical in low proximity installations. The ... throughout its lifetime which is up to four times ... "The investment cost was clearly higher when compared to ...
(Date:12/19/2014)... 2014  Decision Resources Group finds that the ... grow moderately through 2023 as the aging population, increasing ... dental biomaterials all spur procedure volumes. Growth will be ... China and India , ... reach for a larger proportion of the population. ...
(Date:12/19/2014)... , Dec. 18, 2014 Relmada Therapeutics, Inc. ... the treatment of chronic pain, announced the results of ... "This was a transformational year in Relmada,s history ... for our company," said Sergio Traversa , chief ... have executed on key financial, human resource and clinical ...
(Date:12/17/2014)... “Never say, ‘I cannot do ... Department of Physics, advises young women pursuing careers ... SPIE Women in Optics 18-month planner ... ask questions.” , In the annual planner, women ... ranging from university professor and laboratory researcher to ...
Breaking Biology Technology:Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 3Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 2Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 3
... Signal Genetics, the parent company of Myeloma Health ... on oncology, and Caris Life Sciences, Inc., a leading ... through the highest quality anatomic pathology, molecular profiling and ... which Caris Life Sciences will offer Signal Genetics, new ...
... Advanced BioHealing, Inc. (ABH), a leader ... regenerative medicine , today announced that Kevin Rakin ... at the 29th Annual J.P. Morgan Healthcare Conference on Tuesday, ... conference will take place at the Westin St. Francis Hotel ...
... Calif., Jan. 4, 2011 Onyx Pharmaceuticals, Inc. (Nasdaq: ... the 29th Annual J.P. Morgan Healthcare Conference on Monday, January ... Time).   Interested parties may access a live ... http://www.onyx-pharm.com/view.cfm/32/Event-Calendar It is recommended that ...
Cached Biology Technology:Signal Genetics and Caris Life Sciences Announce Commercialization Partnership for New Myeloma Gene Expression Test 2Signal Genetics and Caris Life Sciences Announce Commercialization Partnership for New Myeloma Gene Expression Test 3Advanced BioHealing to Present at 29th Annual J.P. Morgan Healthcare Conference 2Onyx Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference 2
(Date:12/5/2014)... , Dec. 4, 2014 Increased ... boosted investments in new testing and inspection technologies. ... given rise to a range of innovative test ... requirements of Generation Y, which is generally more ... a result, product development strategies of test equipment ...
(Date:12/3/2014)... 2014   Marvin Test Solutions , a ... for military, aerospace, and manufacturing organizations, today announced ... TS-900 PXI semiconductor test platform . The ... systems to customers at a fraction of the ... ATE. "Our semiconductor customers asked ...
(Date:11/21/2014)...  Earlier this year Donald Spector , Chairman ... of the most prolific inventors in the world, got ... Smartphones to third party agencies. Spector envisioned this technology ... the earliest known patents in this area. Now major ... child care, elder care and hospital applications. This technology ...
Breaking Biology News(10 mins):Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4
... about the impact on global climate of water evaporated ... concludes that evaporated water helps cool the earth as ... demonstrating that evaporation of water from trees and lakes ... These findings, published September 14 in Environmental Research ...
... at the University of California, Riverside,s Center for Environmental ... Engineering have received two grants to further explore a ... fuels. "These grants allow for the continued happy ... research engineer at CERT. "This research has the potential ...
... For those fascinated by microbes, infection, or how medical ... Infectious Diseases, a new book just published by ASM Press, ... whose work changed the way we think about and treat ... Gaynes describes the genesis of the germ theory of disease ...
Cached Biology News:Water evaporated from trees cools global climate 2Turning waste into inexpensive, green fuel 2Turning waste into inexpensive, green fuel 3The remarkable history of medicine's battle with infectious diseases 2
... stainless steel rack holders ... mechanism that permits selection ... angles, and "snap-in" product ... rack holder will accomodate ...
... coli RY 13 5'G AATTC3' 3'CTTAA G5' Inactivation ... or ethanol precipitation. Storage Conditions: 10mM Tris-HCl (pH ... Triton X-100, 0.01% BSA, 50% glycerol. Shipping and ... Unit Definition: One unit is defined as the ...
... Heavy duty stainless-steel shaker flask clips, ... high speeds. All clips are equipped ... (over 1L.) also include a bottom retainer ... prevent scratching of expensive glassware. Clips ...
ANTI DIPHTH TOX A SU...
Biology Products: